| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 22, 161-168, Copyright © 1993 by American Heart Association
SC Hunt, SJ Hasstedt, LL Wu and RR Williams
Urinary kallikrein excretion has been shown statistically to be partially
determined by a major gene in large Utah pedigrees with the use of
segregation analysis. A previous twin analysis of environmental factors
influencing urinary kallikrein level showed that urinary potassium twin
differences were strongly related to differences in urinary kallikrein. The
present study uses 769 individuals in 58 Utah pedigrees to analyze the
association of urinary potassium with urinary kallikrein within
statistically inferred kallikrein genotypes. Fitting genotype-specific
curves relating urinary kallikrein level to 12-hour urinary potassium
amount within a major gene, polygene, and common environment model, we
showed a significant statistical urinary potassium interaction with the
inferred major gene for kallikrein (P = .0002). The heterozygotes (with a
frequency of 50%) had a significant association between urinary kallikrein
and potassium (slope, 0.51 +/- 0.04 SD), whereas there was no association
with potassium in the low homozygotes, suggesting a genetic defect
involving the kallikrein response to potassium. The model predicted that an
increase in urinary potassium excretion of 0.8 SD above the mean in these
pedigrees would be associated with high kallikrein levels in the
heterozygotes similar to the high homozygotes. A decrease of 1.3 SD in
urinary potassium excretion in heterozygous individuals was associated with
kallikrein levels similar to the homozygous individuals with low
kallikrein. Because in the steady state urinary potassium represents
dietary potassium intake, this study suggests that an increase in dietary
potassium intake in 50% of these pedigree members, estimated to be
heterozygous at the kallikrein locus, would be associated with an increase
in an underlying genetically determined low kallikrein level.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
A gene-environment interaction between inferred kallikrein genotype and potassium
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
This article has been cited by other articles:
![]() |
P. Meneton, J. Loffing, and D. G. Warnock Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule Am J Physiol Renal Physiol, October 1, 2004; 287(4): F593 - F601. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 15, 2001; (2001) 51619598. [Abstract] [Full Text] |
||||
![]() |
L. Jin, L. Chao, and J. Chao Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR Am J Physiol Renal Physiol, March 1, 1999; 276(3): F476 - F484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hunt, L. L. Wu, P. N. Hopkins, and R. R. Williams Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 912 - 917. [Abstract] [Full Text] |
||||
![]() |
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 27, 2001; 98(5): 2634 - 2639. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |